Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
Jan B. Vermorken(University of Antwerp), Herbert M. Pinedo(Leiden University), Elisabeth Bloemena(Amsterdam Neuroscience), Sybren L. Meijer(University of Amsterdam), Harm van Tinteren(Princess Máxima Center), A.M.E. Claessen(University of Amsterdam), Renate Ezinga(Netherlands Comprehensive Cancer Organisation), Chris J.L.M. Meijer(Dutch Cancer Society), Janet H. Ransom(University of Graz), Helen Gall(University of Amsterdam), Rik J. Scheper(Unknown), Michael G. Hanna(National Hospital for Neurology and Neurosurgery)
Cited by 503
Related Papers
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k
Fluorouracil: biochemistry and pharmacology.
|Journal of Clinical Oncology|1988|834
K-<i>ras</i>Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
|New England Journal of Medicine|1990|811
Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners
|New England Journal of Medicine|2002|806